Pharma investment freeze in Germany deepens as Boehringer and Eli Lilly scale back projects German pharmaceutical investment freeze alarms industry as lawmakers approve higher manufacturer rebates and tougher pricing rules …
The Berlin Herald @2020 – All Right Reserved.